Gutwerg Ori's Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Aug 25, 2023
- Accession no.
- 0001846478-23-000002
- Filed
- Aug 25, 2023
- Trade date
- Aug 23, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $970.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gutwerg OriCIK 0001846478 | Officer (SVP, GENERICS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2023 | Common Stock | MOption exerciseAcquired | +13,502 | $31.49 | +$425,177.98 | 76,476 | Direct | |
| Aug 23, 2023 | Common Stock | SSaleDisposed | −13,502 | $62.39F1 | −$842,389.78 | 62,974 | Direct | |
| Aug 23, 2023 | Common Stock | SSaleDisposed | −2,059 | $62.39F2 | −$128,461.01 | 60,915 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2023 | Common Stock | MOption exerciseDisposed | −13,502 | $31.49 | −$425,177.98 | 13,504 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.31 to $62.68, inclusive.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.32 to $62.50, inclusive.
Referenced by the price of 1 transaction in Table I.